COMPLETEDPhase 1

Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism

This study examined the effects of two commonly prescribed HIV drugs on the way the body metabolizes glucose, insulin and fat.

Sponsor

Bristol-Myers Squibb

Enrollment

25 participants

Sites

1 locations

Start Date

September 2004

Completion

June 2005

HIV InfectionsAtazanavir/Ritonavir/Lopinavir/ritonavir

Enrollment & Timeline

Completed

Target enrollment (estimated)

Target N

participants

Sites

locations

Duration

9 months

total trial span

Rate

pts/month needed

At 1 sites, each site needs to enroll approximately 3.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Insulin sensitivity by euglycemic hyperinsulinemic clamp method

Ask AI

Eligibility

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

No linked publications found in PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Fetching protocol from ClinicalTrials.gov…

COMPLETEDPhase 1

Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism

This study examined the effects of two commonly prescribed HIV drugs on the way the body metabolizes glucose, insulin and fat.

Sponsor

Bristol-Myers Squibb

Enrollment

25 participants

Sites

1 locations

Start Date

September 2004

Completion

June 2005

HIV InfectionsAtazanavir/Ritonavir/Lopinavir/ritonavir

Enrollment & Timeline

Completed

Target enrollment (estimated)

Target N

participants

Sites

locations

Duration

9 months

total trial span

Rate

pts/month needed

At 1 sites, each site needs to enroll approximately 3.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Insulin sensitivity by euglycemic hyperinsulinemic clamp method

Ask AI

Eligibility

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

No linked publications found in PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism

Enrollment & Timeline

Primary Outcomes

Eligibility

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism

Enrollment & Timeline

Primary Outcomes

Eligibility

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Trial Sites (1)